MA47097B1 - Compositions and methods for inhibiting arginase activity - Google Patents

Compositions and methods for inhibiting arginase activity

Info

Publication number
MA47097B1
MA47097B1 MA47097A MA47097A MA47097B1 MA 47097 B1 MA47097 B1 MA 47097B1 MA 47097 A MA47097 A MA 47097A MA 47097 A MA47097 A MA 47097A MA 47097 B1 MA47097 B1 MA 47097B1
Authority
MA
Morocco
Prior art keywords
methods
compositions
arginase activity
inhibiting arginase
inhibiting
Prior art date
Application number
MA47097A
Other languages
French (fr)
Inventor
Matthew Gross
Eric Sjogren
Jim Li
Zandt Michael Van
Darren Whitehouse
Francesco Parlati
Lijing Chen
Roland Billedeau
Timothy Stanton
Gunnar Jagdmann
Lene Petersen
Original Assignee
Calithera Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calithera Biosciences Inc filed Critical Calithera Biosciences Inc
Priority claimed from PCT/US2017/068307 external-priority patent/WO2018119440A1/en
Publication of MA47097B1 publication Critical patent/MA47097B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une nouvelle classe de composés présentant une activité inhibitrice vis-à-vis de l'arginase et des compositions pharmaceutiques comprenant les composés de l'invention. L'invention concerne également des procédés de traitement du cancer à l'aide des inhibiteurs de l'arginase de la présente invention.The invention relates to a novel class of compounds exhibiting inhibitory activity against arginase and pharmaceutical compositions comprising the compounds of the invention. Also provided are methods of treating cancer using the arginase inhibitors of the present invention.

MA47097A 2016-12-22 2017-12-22 Compositions and methods for inhibiting arginase activity MA47097B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662438092P 2016-12-22 2016-12-22
PCT/US2017/068307 WO2018119440A1 (en) 2016-12-22 2017-12-22 Compositions and methods for inhibiting arginase activity

Publications (1)

Publication Number Publication Date
MA47097B1 true MA47097B1 (en) 2021-08-31

Family

ID=65895726

Family Applications (1)

Application Number Title Priority Date Filing Date
MA47097A MA47097B1 (en) 2016-12-22 2017-12-22 Compositions and methods for inhibiting arginase activity

Country Status (2)

Country Link
AR (2) AR110449A1 (en)
MA (1) MA47097B1 (en)

Also Published As

Publication number Publication date
AR110449A1 (en) 2019-03-27
AR126560A2 (en) 2023-10-25

Similar Documents

Publication Publication Date Title
MA43131B1 (en) Compositions and methods of inhibiting arginase activity
MX2020011528A (en) Substituted heterocyclic inhibitors of ptpn11.
MA39219A1 (en) New lrrk2 Kinase Inhibitor Compounds Used to Treat Parkinson's, Alzheimer's and Amyotrophic Lateral Sclerosis
MA40123A1 (en) Pyrimidines used as factor xia inhibitors
EA201990997A1 (en) VISTA DOUBLE INHIBITORS AND WAYS PD-1
MA50949B1 (en) ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF
MA43169B1 (en) Heterocyclic compounds as pi3k-gamma inhibitors
MA45985B1 (en) Diacylglycerol acyltransferase 2 inhibitors
PH12016501338A1 (en) Indazole compounds as irak4 inhibitors
MA41179A (en) PARG INHIBITOR COMPOUNDS
BR112018001303A2 (en) " compounds "
MD3442972T2 (en) Bromodomain inhibitors
PH12017500841A1 (en) 2-amino-6-(difluoromethyl)- 5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as bace1 inhibitors
EA202092086A1 (en) ARGINASE INHIBITORS
MA41238B1 (en) 5 - [(piperazin-1-yl) -3-oxo-propyl] -imidazolidine-2,4-dione derivatives as adamt inhibitors for the treatment of osteoarthritis
MA47736B1 (en) Pyrimidopyrimidinones useful as wee-1 kinase inhibitors
MA44948A1 (en) Bace 1 inhibitors
MA38810B1 (en) Inhibitors of rorc2 related methods of use
MA42776B1 (en) Compounds useful for inhibiting t-ror
MA43052B1 (en) Human Plasma Kallikrein Inhibitors
MA40378B1 (en) Process for the preparation of synthetic intermediates for the preparation of tetrahydroquinoline derivatives
EA202190452A1 (en) CDK8 / 19 INHIBITORS
MA47097B1 (en) Compositions and methods for inhibiting arginase activity
FR3047665B1 (en) CELASTROL AND ITS DERIVATIVES IN THE TREATMENT OF PRE-CANCEROUS SKIN TUMORS AND PATHOLOGIES
MA44383B1 (en) A derivative of 4- (3-pyrazolylamino) -benzimidazole as a jak1 inhibitor for the treatment of cancer